AzTrials
AzTrials

HealthyNCT04749849

The Pregnancy 24/7 Cohort Study

An observational study of Healthy, run by Kara Whitaker at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Moderate to vigorous intensity physical activity is known to reduce the risk of hypertensive disorders of pregnancy and other adverse pregnancy outcomes that increase future maternal cardiovascular disease risk (2018 Physical Activity Guidelines Advisory Committee, 2018; Davenport et al., 2018), yet less than 25% of… Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Healthy
How many people
500 participants
Where
3 sitesUnited States
Study dates
1 Feb 2021to 11 Apr 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Women in their first trimester of pregnancy (10 weeks 0 days - 12 weeks 6 days gestation) who complete eligibility screening: 250 from the Iowa site, 125 from the Pittsburgh site, and 125 from the West Virginia site

Who may be able to join

  • Adult subjects inclusion criteria:
  • Pregnant, <13 weeks gestation
  • 18-45 years of age

Who cannot join

  • Adult subjects exclusion criteria:
  • Taking medications for hypertension or diabetes
  • Medical condition that severely limits physical activity (cannot walk ½ mile or climb 2 flights of stairs)
  • Undergoing treatment for sleep disorders (medication, behavioral treatment, or mechanical therapies)
  • Other serious medical condition (such as systemic lupus, chronic renal disease, hepatitis)
  • Minor subjects inclusion criteria:
  • Mother took part in the Pregnancy 24/7 Study and consented to medical chart abstraction of child

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • University of Iowa

    Iowa City, Iowa, 52240

  • Bethany Barone Gibbs

    Morgantown, West Virginia, 26506

  • University of Pittsburg

    Pittsburgh, Pennsylvania, 15261

Other trials in United States

About this study

Official title: Sedentary Behavior, Physical Activity, Sleep, and Cardiovascular Risk in Pregnancy: the Pregnancy 24/7 Cohort Study

Moderate to vigorous intensity physical activity is known to reduce the risk of hypertensive disorders of pregnancy and other adverse pregnancy outcomes that increase future maternal cardiovascular disease risk (2018 Physical Activity Guidelines Advisory Committee, 2018; Davenport et al., 2018), yet less than 25% of pregnant women meet public health physical activity guidelines (Hesketh \& Evenson, 2016). More than 95% of the 24-hour day is spent in sedentary behavior, sleep, or light-intensity activity; however, the impacts of these lower intensity activities on adverse pregnancy outcomes are unknown. This multi-site observational cohort study (N=500) will leverage state-of-the-art, 24-hour behavior assessment in each trimester of pregnancy and examine associations with adverse pregnancy outcomes to inform guidelines and future interventions designed to improve women's pregnancy and long-term cardiovascular health.

Read the detailed description

The overall goal of this study is to use state-of-the-art monitors to objectively measure the 24-hour behavioral cycle (sedentary behavior, sleep, and physical activity) in each trimester of pregnancy, and to examine associations of these behaviors with hypertensive disorders of pregnancy and other adverse pregnancy outcomes linked with future cardiovascular disease (CVD) risk. For this, 500 women in early pregnancy will be recruited to take part in a multi-site (Universities of Iowa and Pittsburgh) cohort study. Women will wear two state-of-the-art devices for seven days in each trimester of pregnancy to assess sedentary behavior and physical activity (activPAL micro 3) as well as sleep (ActiWatch Spectrum Plus). Hypertensive disorders of pregnancy and other adverse outcomes will be obtained through medical chart abstraction. This project will inform guidelines on optimal 24-hour behavioral patterns in pregnancy, as well as lay the foundation for future studies testing behavioral interventions in pregnancy to achieve optimal outcomes and improve women's long-term cardiovascular health.

Specific Aims:

AIM 1: Examine associations of sedentary behavior patterns with hypertensive disorders of pregnancy. Hypothesis: Women with a consistently high sedentary behavior pattern across trimesters will have higher incidence of gestational hypertension/preeclampsia, after adjustment for MVPA.

AIM 2: Examine associations of sleep patterns with hypertensive disorders of pregnancy. Hypothesis: Women with short sleep duration or poor sleep quality patterns across trimesters will have higher incidence of gestational hypertension/preeclampsia, after adjustment for MVPA.

AIM 3: Determine optimal 24-hour behavioral patterns during pregnancy to reduce the risk of hypertensive disorders of pregnancy. Hypothesis: Statistically reallocating time in sedentary behavior for LPA or MVPA, but not sleep (among adequate duration sleepers), will be associated with lower incidence of gestational hypertension/preeclampsia.

Significance: Pregnancy is a critical period for future cardiovascular health where unmasked cardiovascular disease (CVD) risk factors contribute to the development of maternal CVD later in life (Catov, 2015). The American Heart Association (AHA) now recognizes adverse pregnancy outcomes, including gestational hypertension and preeclampsia as key risk factors for CVD (Mosca et al., 2011). CVD remains the leading cause of mortality among women in the United States, accounting for one-third of all deaths (Benjamin et al., 2018). Stagnant CVD rates in young women are a particular public health problem. While overall CVD mortality rates have decreased over the last 20 years, mortality rates in women younger than 55 years have plateaued (Benjamin et al., 2018; Wilmot, O'Flaherty, Capewell, Ford, \& Vaccarino, 2015). In order to reduce the burden of CVD, it is essential to focus on populations who are more likely to develop CVD risk factors, including women of reproductive age. Identifying modifiable behavioral factors that are associated with adverse pregnancy outcomes could help prevent these conditions and the long-term risk they bring to women.

Based on guidelines, women during pregnancy should generally 'move more and sit less' throughout the day (2018 Physical Activity Guidelines Advisory Committee, 2018). While there is currently insufficient evidence to define specific quantitative targets for limiting sedentary behavior in the general population or pregnant women, the 2018 Physical Activity Guidelines Advisory Committee highlighted sedentary behavior and pregnancy as two key topics in need of further research. The American College of Obstetricians and Gynecologists (ACOG) also does not have sedentary behavior guidelines during pregnancy, although growing evidence suggests prescribed bed rest may actually increase the risk of adverse pregnancy outcomes, rather than decreasing risk as previously thought (Matenchuk et al., 2019). Guidelines also suggest that pregnant women should sleep 7 to 9 hours per night on a regular basis (Watson et al., 2015). Yet, uncertainty remains about the health effects of short or long sleep duration during pregnancy, as well as how sleep quality influences pregnancy outcomes.

In Aim 1, the proposed research will inform quantitative guidelines for sedentary behavior patterns and the development of cardiovascular risk during pregnancy. Aim 2 will address existing gaps by evaluating objectively-measured sleep quantity and quality to understand nuances in sleep across pregnancy and implications for health outcomes. As established guidelines recommend pregnant women get 150 minutes of aerobic MVPA per week or approximately 20-30 minutes per day, this is not the focus of the current study. However, MVPA is an important component of the 24-hour behavioral cycle and must be assessed to understand which 24-hour behavioral patterns are most associated with optimal cardiovascular health during pregnancy, as proposed in Aim 3. Our primary outcome of interest is hypertensive disorders that develop during pregnancy (gestational hypertension and preeclampsia) given the high and rising prevalence of these conditions, strong association with future maternal CVD, and promising pilot data indicating that sedentary behavior may be associated with these conditions, even after adjustment for MVPA.

Examining the dynamic interplay of sedentary behavior, sleep, and physical activity (conceptualized as a 24-hour behavioral cycle) is critical to determine optimal patterns for pregnancy health. Given that there is a finite amount of time in a day, increasing time in one behavior requires decreasing time in another behavior. The effects of sedentary behavior, sleep, and physical activity on health outcomes are not only dependent on each behavior, but also on the behavior that they displace (Mekary, Willett, Hu, \& Ding, 2009). While these behaviors are often studied in isolation, this new paradigm considers the importance of examining the combined role of sedentary behavior, sleep, and physical activity on health outcomes (Buman et al., 2014). Emerging statistical methods to test hypotheses within finite time constraints will allow us to better understand the full 24-hour behavioral cycle and how these activity domains can be coupled and leveraged for health promotion and disease prevention. This study will address a critical gap in knowledge by examining how the 24-hour behavioral cycle is related to hypertensive disorders of pregnancy or other adverse outcomes that increase CVD risk.

In summary, preventing hypertensive disorders of pregnancy and other adverse outcomes is a potentially potent public health approach to reduce the burden of CVD in women. In the context of increasing incidence and limited treatment options, there is a critical need to identify novel, modifiable intervention targets that could prevent adverse pregnancy outcomes and improve women's cardiovascular health.

Conditions
Healthy
Keywords
Pre-Eclampsia, Hypertension, Pregnancy-Induced, Pregnancy Complications, Sedentary Behavior, Physical Activity, Sleep
Medical subject headings
Pre-Eclampsia, Hypertension, Pregnancy-Induced, Pregnancy Complications, Sedentary Behavior, Motor Activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hypertensive disorders of pregnancy

    Gestational hypertension and preeclampsia, assessed through medical chart review

    Measured: Through study completion for each participant, an average of 7.5 months after enrollment

Secondary outcomes (6)
  1. Gestational diabetes

    Assessed through medical chart review

    Measured: Through study completion for each participant, an average of 7.5 months after enrollment

  2. Preterm delivery

    Defined as delivery <37 weeks gestation, assessed through medical chart review

    Measured: At study completion for each participant (delivery), an average of 7.5 months after enrollment

  3. Low birth weight

    Defined as birthweight<10th percentile for gestational age, assessed through medical chart review

    Measured: At study completion for each participant (delivery), an average of 7.5 months after enrollment

  4. All adverse pregnancy outcomes (composite)

    Composite measure including gestational hypertension, preeclampsia, gestational diabetes, preterm delivery, and low birth weight, assessed through medical chart review

    Measured: Through study completion for each participant, an average of 7.5 months after enrollment

  5. Blood pressure

    Assessed during the first trimester study visit and through medical chart review

    Measured: Through study completion for each participant, an average of 7.5 months after enrollment

  6. Glycemic control

    From glucose tolerance test, assessed through medical chart review

    Measured: Through study completion for each participant, an average of 7.5 months after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2021
  2. Study start1 Feb 2021
  3. Primary completion18 Feb 2025
  4. Study completion11 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04749849
Sponsor's protocol ID
202002630
Other IDs
R01HL153095
Status last verified
May 2025
First submitted
4 Feb 2021
Last updated
23 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual deidentified data that are relevant to the primary aims of the study will be made available along with a relevant data dictionary.

Publications

  • Nuckols VR, Davis KG, Pierce GL, Gibbs BB, Whitaker KM. Associations of physical activity and sedentary time with aortic stiffness and autonomic function in early pregnancy. J Appl Physiol (1985). 2025 Mar 1;138(3):774-782. doi: 10.1152/japplphysiol.00889.2024. Epub 2025 Feb 14.

    PubMed 39951544
  • Kozai AC, Jones MA, Borrowman JD, Hauspurg A, Catov JM, Kline CE, Whitaker KM, Gibbs BB. Patterns of physical activity, sedentary behavior, and sleep across pregnancy before and during two COVID pandemic years. Midwifery. 2025 Feb;141:104268. doi: 10.1016/j.midw.2024.104268. Epub 2024 Dec 18.

    PubMed 39721225
  • Gallagher JB, Boonstra DE, Borrowman JD, Unke M, Jones MA, Kline CE, Barone Gibbs B, Whitaker KM. Comparing Multiple Approaches to Estimate Physical Activity, Sedentary Behavior, and Sleep in Pregnancy. J Meas Phys Behav. 2024 Jan;7(1):jmpb.2024-0007. doi: 10.1123/jmpb.2024-0007. Epub 2024 Nov 19.

    PubMed 39949639
  • Gibbs BB, Jones MA, Whitaker KM, Ross ST, Davis KK. Measurement of Barriers, Attitudes, and Expectations for Sitting Less in Pregnancy. Am J Health Behav. 2021 Nov 15;45(6):956-970. doi: 10.5993/AJHB.45.6.1.

    PubMed 34969408
  • Whitaker KM, Jones MA, Wallace MK, Catov J, Barone Gibbs B. Associations of objectively measured physical activity and sedentary time with pregnancy-specific health-related quality of life. Midwifery. 2022 Jan;104:103202. doi: 10.1016/j.midw.2021.103202. Epub 2021 Nov 11.

    PubMed 34801955
  • Paley JL, Jones MA, Catov JM, Whitaker KM, Kozai AC, Barone Gibbs B. Associations of Physical Activity and Sedentary Behaviors with Depressive Symptoms and Mood Disturbance Throughout Pregnancy. J Womens Health (Larchmt). 2024 Aug;33(8):1128-1138. doi: 10.1089/jwh.2023.0419. Epub 2024 Feb 6.

    PubMed 38324012
  • Jones MA, Whitaker KM, Paley JL, Thrower A, Stoner L, Barone Gibbs B. Brachial-femoral pulse wave velocity in 2-4-year-old children: a feasibility study. Blood Press Monit. 2023 Feb 1;28(1):11-16. doi: 10.1097/MBP.0000000000000622. Epub 2022 Nov 1.

    PubMed 36606476
  • Jones MA, Whitaker KM, Taverno Ross SE, Davis K, Libertus K, Barone Gibbs B. Maternal Sedentary Behavior and Physical Activity across Pregnancy and Early Childhood Motor Development. Children (Basel). 2021 Jun 25;8(7):549. doi: 10.3390/children8070549.

    PubMed 34201936
  • Jones MA, Whitaker K, Taverno Ross SE, Davis K, Libertus K, Gibbs BB. Maternal Sedentary Behavior and Physical Activity across Pregnancy and Early Childhood Growth. Child Obes. 2022 Sep;18(6):399-408. doi: 10.1089/chi.2021.0202. Epub 2022 Feb 2.

    PubMed 35108109
  • Jones MA, Diesel SJ, Gibbs BB, Whitaker KM. Concurrent Agreement Between ActiGraph and activPAL for Measuring Physical Activity in Pregnant Women and Office Workers. J Meas Phys Behav. 2022 Jun;5(2):69-75. doi: 10.1123/jmpb.2021-0050. Epub 2022 Apr 23.

    PubMed 36340243
  • Whitaker KM, Jones MA, Smith K, Catov J, Feghali M, Kline CE, Santillan M, Santillan D, Zimmerman B, Gibbs BB. Study Design and Protocol of the Multisite Pregnancy 24/7 Cohort Study. Am J Epidemiol. 2024 Feb 5;193(3):415-425. doi: 10.1093/aje/kwad208.

    PubMed 37939072
  • Borrowman JD, Crisp AH, Jones MA, Catov JM, Gibbs BB, Whitaker KM. Prepregnancy Body Mass Index, Pregnancy Physical Activity Trajectories, and Postpartum Blood Pressure. J Am Heart Assoc. 2026 Sep 9:e051063. doi: 10.1161/JAHA.126.051063. Online ahead of print.

    PubMed 42714460

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy, run by Kara Whitaker at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hypertensive disorders of pregnancy (time frame: Through study completion for each participant, an average of 7.5 months after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04749849, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in